CSF IL-17 acts as a potent inflammatory mediator by inducing cytokines and promoting monocyte and neutrophil recruitment to the inflammation site, and is elevated in patients with multiple sclerosis and Neuromyelitis optica [32, 33] [34] [35]. Here, IL17A is linked to neuromyelitis optica.